Stocks Ended Higher, Eyed on Vaccine Updates and Earnings

U.S. stocks ended higher on Wednesday, as investors considered a spate of updates around companies’ coronavirus vaccine development and distribution plans, alongside a batch of stronger than expected corporate earnings results. The Dow Jones Industrial Average rose 373.05 points, or 1.39%, to 27,201.52. The S&P 500 gained 21.26 points, or 0.64%, to 3,327.77. The Nasdaq Composite advanced 57.23 points, or 0.52%, to 10,998.40.

Oil futures posted the highest close in five months, after data confirmed a large drop in crude inventories while also showing an unexpected rise in gasoline stocks that undercut notions of a pickup in demand. West Texas Intermediate crude for September delivery rose 49 cents, or 1.2% to finish at $42.19 a barrel. October Brent crude was up 74 cents, or 1.7%, at $45.17 a barrel.

Johnson & Johnson (JNJ) announced it had entered an agreement with the US government to manufacture and deliver 100 million doses of its Janssen unit’s investigational coronavirus vaccine candidate.


Posted

in

by

Tags:

Comments

Leave a Reply